Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis

@article{Leocani2018VisualEP,
  title={Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis},
  author={Letizia Leocani and Simone Guerrieri and Giancarlo Comi},
  journal={Journal of Neuro-Ophthalmology},
  year={2018},
  volume={38},
  pages={350–357}
}
&NA; From the Section Editor: The next two installments in the JNO “Disease of the Year: Multiple Sclerosis” series focus on lessons that can be learned form the afferent visual pathway, as a putative model of MS. In their article entitled, “Visual evoked potentials as a biomarker in multiple sclerosis and associated optic neuritis” Leocani and colleagues highlight the role of visual evoked potential (VEP) testing as a means of capturing the effects of demyelination, remyelination, and… 
The Comparison of VEP Parameters in Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis Patients with Acute Optic Neuritis
TLDR
VEP findings in early-stage acute optic neuritis can be used to differentiate clinically challenging both seropositive and seronegative NMOSD patients from patients with MS in the early period.
Multimodal Evoked Potentials as Candidate Prognostic and Response Biomarkers in Clinical Trials of Multiple Sclerosis.
  • M. Hardmeier, P. Fuhr
  • Psychology, Biology
    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
  • 2021
SUMMARY Evoked potentials (EPs) measure quantitatively and objectively the alterations of central signal propagation in multiple sclerosis and have long been used for diagnosis. More recently, their
Optic Nerve Topography in Multiple Sclerosis Diagnosis
TLDR
The addition of the optic nerve as a fifth region in the current DIS criteria slightly improves the diagnostic performance because it increases sensitivity without losing specificity.
Histological and Top-Down Proteomic Analyses of the Visual Pathway in the Cuprizone Demyelination Model
TLDR
It is indicated that continuous CPZ-feeding, which evokes a slow demyelination, results in proteomic changes that precede any clear histological changes in the visual pathway and that these proteoforms may be potential early markers of degenerative demYelinating conditions.
Atypical optic neuritis: An overview.
Optic neuritis (ON) refers to conditions that involve inflammation of the optic nerve. Various autoantibodies have been found, which are associated with central nervous system inflammatory disorders
Citicoline: A Candidate for Adjunct Treatment of Multiple Sclerosis
TLDR
Citicoline, known for many years as a nootropic and neuroprotective drug and recently pronounced food supplement, has been found to be significantly efficacious in two complementary rodent models of MS, experimental autoimmune encephalomyelitis (EAE) and cuprizone-induced myelin toxicity.
Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis
TLDR
A machine learning analysis of motor EP that uses the whole time series, instead of a few variables, to predict disability progression after two years, shows promising predictive performance.
Facing the urgency of therapies for progressive MS — a Progressive MS Alliance proposal
TLDR
The reasons behind the focus on experimental medicine trials, the strengths and weaknesses of these approaches and of the programme, and why are discussed are discussed, which hope to advance therapies while improving the understanding of progression in MS.
Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues.
  • M. Skeen, L. Pani
  • Medicine, Psychology
    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society
  • 2021
TLDR
Regulatory issues regarding the use of biomarkers and surrogate end points in clinical trials of multiple sclerosis are explored with particular emphasis on challenges faced by evoked potential studies.
PARÂMETROS CLÍNICOS, BIOLÓGICOS E MOLECULARES NA RESPOSTA AO TRATAMENTO COM INTERFERON-BETA EM PACIENTES COM ESCLEROSE MÚLTIPLA
TLDR
This immunomodulator therapy has demonstrated satisfactory results showing a decrease of relapses and of symptoms exacerbation, however, it has been observed a range of different response profiles between treated patients, that may be due to genetic and molecular factors.
...
...

References

SHOWING 1-10 OF 119 REFERENCES
The visual pathway as a model to understand brain damage in multiple sclerosis
TLDR
The visual pathway represents a model of acute focal central nervous system (CNS) damage, through acute optic neuritis and retinal periphlebitis, as well as a models of chronic, diffuse CNS damage through chronic retinopathy and optic neuropathy.
Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives.
TLDR
Optic neuritis as a prototypic autoimmune demyelinating disease offers an option for testing new therapies targeting key deleterious processes in multiple sclerosis and the window of opportunity for therapeutic interventions is opened.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica
TLDR
Evaluation of VEP in patients with definite NMO revealed a pattern that is different from that of MS in 81.6% of eyes examined, characterized by the absence of responses, or decreased amplitude with normal latency.
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis
TLDR
The parameters and merits of the AVP model, a functionally eloquent system that is amenable to interrogation with highly reliable and reproducible tests that can be used to define a structural-functional paradigm of CNS injury, are highlighted.
Latency of multifocal visual evoked potentials in nonoptic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions.
TLDR
The hypothesis that latency delay of the mfVEP in eyes of MS patients without previous ON is related to retrogenicular demyelinating lesions is supported and a previous episode of ON in the fellow eye may be a significant confounding factor, masking the relationship between the latency and OR lesions.
Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis
TLDR
The magnitude of latency prolongation and amplitude decline 12 months after the initial episode of unilateral optic neuritis was proportional to the risk of MS.
MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis
TLDR
Optic nerve total lesion length and area on the STIR sequence was found to correlate significantly with prolongation of the VEP latency, which may reflect a predominantly demyelinating rather than inflammatory origin for the signal change in the optic nerve.
Axonal loss in non–optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential
TLDR
There was significant association between RNFL loss and a latency delay of the mfVEP in MS-NON eyes, and in patients with no previous optic neuritis in either eye, delayed latency and reduced RNFL were bilateral whenever present.
...
...